Skip to main content
Premium Trial:

Request an Annual Quote

Tecan, Invitrogen Unit Combine Liquid-Handling, Magnetic Bead Technologies

NEW YORK, Oct. 21 (GenomeWeb News) - Tecan plans to combine its  Freedom EVO automated liquid-handling platforms with magnetic bead technology made by Invitrogen subsidiary Dynal to enable researchers isolate biological starting material, including mRNA, DNA, and recombinant proteins, the firms said today.

 

The Freedom EVO series, which offers a variety of liquid-handling and robotic-arm options, complements the bead technology, called Dynabeads, which are compatible with many molecular tags. This makes it possible for researchers to isolate and concentrate cells, DNA, mRNA, organelles, and proteins from different kinds of sources.

 

Financial terms of the alliance were not disclosed.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.